Literature DB >> 14739096

Commitment of bone marrow cells to hepatic stellate cells in mouse.

Shinji Baba1, Hideaki Fujii, Tetsuro Hirose, Kentaro Yasuchika, Hisaya Azuma, Toshitaka Hoppo, Masato Naito, Takafumi Machimoto, Iwao Ikai.   

Abstract

BACKGROUND/AIMS: Recently, several cells found within the liver have been reported to derive from bone marrow (BM). This study sought to examine the commitment of BM cells to hepatic stellate cell (HSC) lineage in mouse liver.
METHODS: We transplanted BM cells from green fluorescent protein (GFP) transgenic mice into age-matched C57BL/J mice. Hepatic nonparenchymal cells were isolated from the livers of BM-transplanted mice using density gradient centrifugation with Nycodenz. The expression of lineage markers by the isolated cells was evaluated by RT-PCR and immunostaining. We then examined the histology of liver tissues obtained from BM-transplanted mice with and without carbon tetrachloride-induced injury.
RESULTS: GFP-expressing cells with intracytoplasmic lipid droplets comprised 33.4 +/- 2.3% of the cells isolated by density gradient centrifugation. These cells expressed the HSC lineage markers, such as desmin and glial fibrillary acidic protein (GFAP), by both RT-PCR and immunostaining. During a 7-day culture, GFP-positive cells began to express alpha-smooth muscle actin, a marker of activated HSC. In the liver of BM-transplanted mice, GFP-positive nonparenchymal cells expressed GFAP and extended their process around hepatocytes. Upon liver injury, these cells also co-expressed desmin and alpha-smooth muscle actin.
CONCLUSIONS: Nonparenchymal cells, derived from transplanted BM, acquired HSC characteristics in both quiescent and activated states.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739096     DOI: 10.1016/j.jhep.2003.10.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  48 in total

Review 1.  Targeting collagen expression in alcoholic liver disease.

Authors:  Kyle J Thompson; Iain H McKillop; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Chun-Yan Zhang; Lang Zhuo
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

4.  Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance.

Authors:  Sheng Xia; Zhenhong Guo; Xiongfei Xu; Hai Yi; Quanxing Wang; Xuetao Cao
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

Review 5.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

6.  Hepatic antigen-presenting cells and regulation of liver transplant outcome.

Authors:  Angus W Thomson; David A Geller; Chandrashekhar Gandhi; Noriko Murase; A Jake Demetris; Donna Beer-Stolz
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 7.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

8.  Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells.

Authors:  E Novo; F Marra; E Zamara; L Valfrè di Bonzo; A Caligiuri; S Cannito; C Antonaci; S Colombatto; M Pinzani; M Parola
Journal:  Gut       Date:  2005-07-24       Impact factor: 23.059

Review 9.  Cellular sources of extracellular matrix in hepatic fibrosis.

Authors:  Rebecca G Wells
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

10.  Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.

Authors:  Angela Douglass; Karen Wallace; Matthew Koruth; Caroline Barelle; Andrew J Porter; Matthew C Wright
Journal:  Hepatol Int       Date:  2008-09-03       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.